Sentinel Lymph Node Mapping in Detecting Cancer That Has Spread to Lymph Nodes in Patients With Non-Small Cell Lung Cancer
RATIONALE: Diagnostic procedures such as sentinel lymph node mapping may improve the ability to detect cancer that has spread to the lymph nodes. PURPOSE: This clinical trial is studying how well sentinel lymph node mapping works in detecting cancer that has spread to the lymph nodes in patients who are undergoing surgery for stage I non-small cell lung cancer.
Checked against the public recordLast updated Jun 30, 2016 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Diagnostic
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- Alliance for Clinical Trials in Oncology
- Interventions being studied
- Radiation: technetium-99
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
1. Patients with clinical stage I lung cancer for whom surgical resection is planned are eligible. Histologic confirmation of lung cancer is not required prior to registration or surgical exploration. Preoperative mediatinoscopy is allowed but not required in those patients with indications for mediatinoscopy. It is preferred that that mediatinoscopy be done at a different setting (prior to registration), but the procedure may be done at the same setting as the lobectomy. 2. No prior therapy for this diagnosis. 3. No prior treatment with mediastinal radiation therapy. 4. Age ≥ 18 years of age. 5. ECOG performance status: 0-2.
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Beebe Medical CenterLewes, Delaware
- CCOP - Christiana Care Health ServicesNewark, Delaware
- Evanston Northwestern Healthcare - Evanston HospitalEvanston, Illinois
- Veterans Affairs Medical Center - Columbia (Truman Memorial)Columbia, Missouri
- Cancer Institute of New Jersey at Cooper - VoorheesVoorhees Township, New Jersey
- Roswell Park Cancer InstituteBuffalo, New York
- Elmhurst Hospital CenterElmhurst, New York
- Queens Cancer Center of Queens HospitalJamaica, New York
- Mount Sinai Medical CenterNew York, New York
- SUNY Upstate Medical University HospitalSyracuse, New York
- Veterans Affairs Medical Center - AshevilleAsheville, North Carolina
- Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State UniversityColumbus, Ohio
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Jun 30, 2016. Always confirm current availability with the study team.